Comparable stake leader
GAGNON SECURITIES LLC
SEC ownership of Profound Medical Corp.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001628808.
Disclosed value leader
GAGNON SECURITIES LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- PROF on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
GAGNON SECURITIES LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
GAGNON SECURITIES LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001628808
- Issuer location
- Mississauga, Ontario, Canada
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Profound Medical Corp. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GAGNON SECURITIES LLC
Disclosed value leader
GAGNON SECURITIES LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: GAGNON SECURITIES LLC
Showing 1-8 of 50 holder rows.
Quick read
GAGNON SECURITIES LLC leads the comparable SEC ownership view at 11%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GAGNON SECURITIES LLC's linked filing trail.
Comparable ownership
Top 5
GAGNON SECURITIES LLC
11%
LETKO, BROSSEAU & ASSOCIATES INC
4.9%
Arun S. Menawat
2%
FIL Ltd
7.9%
ROYCE & ASSOCIATES LP
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GAGNON SECURITIES LLC |
13D/G
13F
Neil Gagnon · Company
|
11%
|
$15,796,627
3,346,743 shares
|
$0 | 31 Dec 2024 |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
13D/G
Company
|
4.9%
from 13D/G
|
$5,403,226
935,725 shares
|
— | 30 Jun 2026 |
| Arun S. Menawat |
3/4/5
CEO, Director
|
2%
|
$2,776,930
587,089 shares
|
— | 15 May 2025 |
| FIL Ltd |
13F
Company
|
7.9%
|
$15,760,496
2,370,000 shares
|
— | 30 Jun 2026 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
4%
|
$7,975,948
1,199,564 shares
|
— | 30 Jun 2026 |
| Timelo Investment Management Inc. |
13F
Company
|
3.7%
|
$7,414,531
1,114,967 shares
|
— | 30 Jun 2026 |
| Gagnon Advisors, LLC |
13F
Company
|
3.2%
|
$6,398,537
962,186 shares
|
— | 30 Jun 2026 |
| Rosalind Advisors, Inc. |
13F
Company
|
2.8%
|
$5,506,985
828,118 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-1 of 1 reporting-owner rows connected to Profound Medical Corp.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
1
Largest Forms 3/4/5 holder
Arun S. Menawat
Net 12M change
$0
Latest report
15 May 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Arun S. Menawat | CEO, Director | $2,776,930 | Filing P/S | 15 May 2025 |
Recent insider transactions for Profound Medical Corp.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.